 LONDON and RALEIGH, N.C., Oct. 26, 2021 GLOBE NEWSWIRE -- Verona Pharma plc Nasdaq: VRNA Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the three and nine months ended September 30, 2021 on Tuesday, November 9, 2021 and host an investment community conference call at 9:00 a.m. EST 2:00 p.m. GMT to discuss these financial results and provide a corporate update. 